Home > Healthcare > Medical Devices > Diagnostic Devices > Robotic Medical Imaging Market
Robotic Medical Imaging Market size was valued at more than USD 3.2 billion in 2022 and is projected to record over 12.5% CAGR from 2023 to 2032. Emerging demand for advanced imaging solutions in the healthcare sector will fuel market development.
Increasing advancements in the field of robotics and medical surgery technology will support market expansion. Robotic imaging technology is helping doctors attain medical images with high precision and accuracy. The technology has seen significant developments in recent years with innovations in digital twin technology, 2D and 3D endoscopy, artificial intelligence (AI), and virtual healthcare.
Report Attribute | Details |
---|---|
Base Year: | 2022 |
Robotic Medical Imaging Market Size in 2022: | USD 3.2 Billion |
Forecast Period: | 2023 to 2032 |
Forecast Period 2023 to 2032 CAGR: | 12.5% |
2032 Value Projection: | USD 10 Billion |
Historical Data for: | 2018 to 2022 |
No. of Pages: | 178 |
Tables, Charts & Figures: | 210 |
Segments covered: | Product, End-use and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|
Medical equipment companies are developing new robotic imaging systems that can lessen the workload of healthcare workers and provide precise diagnoses. For example, in July 2022, Siemens Healthineers introduced a 3D imaging device with endoluminal robotics for precise transbronchial lung biopsy. This robotic-assisted sensing bronchoscopy biopsy is made to find all lung lesions with the fewest complications possible. Such product launches will fuel the market demand.
The high cost of robotic imaging systems and their low adoption rate across developing countries could hamper the robotic medical imaging market growth. For instance, the average selling price (ASP) of a robotic imaging system is approximately USD $1 million, while the ASP of other imaging systems is approximately USD $100,000. Investments in extensive research and the use of cutting-edge technology in the creation of these gadgets will raise the cost of production. Furthermore, the development of new medical imaging solutions that give doctors the freedom to diagnose numerous tests using a single robotic solution could raise complexity and the cost of production of these robots.
Robotic medical imaging market share from the X-rays devices segment is anticipated to surpass USD 2.5 billion by 2032 as they make disease diagnostics painless and non-invasive. Robots make it possible to scan materials with x-rays from different angles, which improves and simplifies the process of finding medical anomalies. In February 2023, MedTech start-up Nanoflex Robotics has secured $12 million financing to commercialize its robotic platform and accelerate the development of new neuro-interventional products.
Robotic medical imaging market from the hospital end-use is anticipated to observe nearly 13% CAGR from 2023 to 2032. Patients prefer hospitals for medical treatments as they offer multiple benefits like cutting-edge infrastructure and availability of highly skilled professionals. Hospitals are upgrading their infrastructure with cutting-edge medical equipment to improve patient experience and offer quality healthcare services. The increasing hospitalization rate is another factor contributing to the demand for robotic medical imaging.
Europe robotic medical imaging market is expected to reach over USD 2.9 billion by 2032 due to the high level of disposable income and medical expenditure in the region. As per a study by Eurostat, in 2020, the EU Member States, France (12.2 %) and Germany (12.8 %) had the highest healthcare expenditure relative to GDP. Strategic expansion activities by regional industry players to strengthen their market position and broaden their product line is expected to promote market development.
The global robotic medical imaging market is inclusive of companies like
Strategic initiatives by these companies are expected to drive the market development in the coming years. In September 2021, BK Medical, a pioneer in imaging and surgical navigation, was acquired by GE Healthcare. In addition to helping surgeons during robotic and minimally invasive procedures, these tools are employed in ultrasonography urology, neurosurgery, and abdominal surgery to help surgeons see deep tissue.
The COVID-19 pandemic led to a serious public health crisis and had a negative effect on the market. Almost all elective and non-essential surgical procedures were postponed during the pandemic. However, an increase in popularity and usage of robotic imaging equipment in healthcare facilities is estimated to shape the future of the robotic medical imaging industry over the forecast years 2023 to 2032.
Click here to Buy Section of this Report
By Product
By End-use
The above information is provided for the following regions and countries: